Dr. Scott Antonia is a recognized leader in the research and clinical application of immunotherapy for the treatment of malignant pleural mesothelioma and lung cancer. He practices at the Duke Cancer Institute (DCI), is a member of the Duke Human Vaccine Institute, and is the Director of the DCI Center for Cancer Immunotherapy, which aims
Dr. Ciunci is an Associate Professor of Clinical Medicine (Hematology-Oncology) and a medical oncologist at the Hospital of the University of Pennsylvania and the Abramson Cancer Center at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania. Her clinical expertise is in thoracic malignancies including malignant pleural mesothelioma and lung cancer. Dr. Ciunci is part of the
Dr. Thompson is a medical oncologist who treats patients diagnosed with lung cancer, malignant pleural mesothelioma, thymoma, and thymic tumors. He practices at the Froedtert Hospital Cancer Center affiliated with the Medical College of Wisconsin in Milwaukee, Wisconsin. Speaking of the care he provides, Dr. Thompson says, “The diagnosis of cancer is life-changing. Fortunately, the
Dr. Alberto A. Chiappori is a medical and thoracic oncologist at the Moffitt Cancer Center and Research Institute in Tampa, Florida. He is a Senior Member of Oncology and Medicine for the Thoracic Oncology Program. He specializes in treating patients diagnosed with lung cancers and malignant pleural mesothelioma, as well as pleural neoplasms. Dr. Chiappori
Dr. Michael Shafique is a thoracic oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with lung cancers, malignant pleural mesothelioma, neuroendocrine tumors, Pancoast tumors, and thymomas, as well as gynecologic malignancies. Dr. Shafique is actively involved in recruiting patients into early-phase clinical trials, particularly those that leverage innovative immunotherapy
Dr. Alexander I. Spira is a medical oncologist and Co-Director at Virginia Cancer Specialists, a Fairfax, Virginia multidisciplinary practice of medical oncologists, hematologists, surgeons, palliative care physicians, nurse practitioners, and physician assistants supported by social workers, dietitians, oncology nurses and oncology pharmacists. Board-certified in Medical Oncology and Internal Medicine, Dr. Spira is actively involved in
Dr. Gregory Michael Lubiniecki is a medical oncologist who specializes in treating patients with lung cancer and malignant pleural mesothelioma at Temple Health’s Fox Chase Cancer Center in Philadelphia, Pennsylvania. Though he left full-time practice to accept a role overseeing cancer research at Merck & Company, he believes it is important both personally and professionally
Dr. Antoinette J. Wozniak is a medical oncologist and Chief Scientific Officer of the Lung Cancer Research Foundation. Most recently Professor of Medicine in the division of Hematology and Oncology at the University of Pittsburgh, leader of the Lung Cancer Disease Center, and Associate Director for Clinical Research at UPMC Hillman Cancer Center in Pittsburgh,
Dr. Frank V. Fossella is a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has been providing expert patient care to patients diagnosed with malignant mesothelioma and lung cancer for almost 50 years and has distinguished himself through research seeking treatment options that deliver improved patient outcomes.
Dr. Misako Nagasaka is an accomplished thoracic oncologist and clinical researcher whose use of novel drug protocols has made a significant difference for her lung cancer and mesothelioma patients, as well as for those diagnosed with thyroid cancer. She practices at the University of California-Irvine in Orange, California. In addition to patient care, Dr. Nagasaka’s